Philadelphia-Positive B-Cell Acute Lymphoblastic Leukemia Is Initiated in an Uncommitted Progenitor Cell

References

• Sánchez-García I. Consequences of chromosomal abnormalities in tumour development. Annu. Rev. Genetics 1997; 31: 429–453
   PubMed Web of Science ®Google Scholar
• Konopka J. B., Watanabe S. M., Witte O. N. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035–1042
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature 1985; 315: 550–554
   PubMed Web of Science ®Google Scholar
• Mes-Masson A.-M., McLaughlin J., Daley G. Q., Paskind M., Witte O. N. Overlapping cDNA clones define the complete coding region from the p210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc. Natl. Acad. Sci. USA 1986; 83: 9768–9772
   PubMed Web of Science ®Google Scholar
• Clark S. S., McLaughlin J., Crist W. M., Champlin R., Witte O. N. Unique forms of the abl tyrosine kinase distinguish Ph1-Positive CML from Ph1-positive ALL. Science 1987; 235: 85–88
   PubMed Web of Science ®Google Scholar
• Daley C. G., McLaughlin J., Witte O. N., Baltimore D. The CML-specific p210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science 1987; 237: 532–535
   PubMed Web of Science ®Google Scholar
• Hermans A., et al. Unique forms of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 1987; 51: 33–40
   PubMed Web of Science ®Google Scholar
• Elefanty A. G., Hariharan I.K., Cory S. Bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hemopoieitc neoplasms in mice. EMBO J. 1990; 9: 1069–1078
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Jenster G., Hoeve H. T., Zovich D., Pattengale P. K., Groffen J. Acute leukemia in bcr/abl transgenic mice. Nature 1990; 344: 251–253
   PubMed Web of Science ®Google Scholar
• Kelliher M. A., McLaughlin J., Witte O. N., Rosenberg N. Induction of chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc. Natl. Acad. Sci. USA 1990; 87: 6649–6653
   PubMed Web of Science ®Google Scholar
• Gishizhy M. L., Johnson-White J., Witte O. N. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc. Natl. Acad. Sci. USA 1993; 90: 3755–3759
   PubMed Web of Science ®Google Scholar
• Sánchez-Garcia I., Grütz G. The tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL-2. Proc. Natl. Acad. Sci. U.S.A 1995; 92: 5287–5291
   PubMed Web of Science ®Google Scholar
• Castellanos A., Pintado B., Weruaga E., Arévalo R., Apez A., Orfao A., Sánchez-García I. Acute leukaemia in chimeric mice by a bcr-ABLp190 fusion gene made by homologous recombination. Blood 1997; 90: 2168–2174
   PubMed Web of Science ®Google Scholar
• Fialkow P. J. Clonal evolution of human myeloid leukemias. Genes and Cancer, J.M. Bishop, J.D. Rowley, M. Greaves. Liss, New york, NY 1984; 215–223
   Google Scholar
• Cline M. J. Mechanisms of disease-The molecular basis of leukemia. N. Engl. J. Med 1994; 330: 328–336
   PubMed Web of Science ®Google Scholar
• Copelan E. A., McGuire E. A. The Biology and Treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151–1168
   PubMed Web of Science ®Google Scholar
• Sánchez-García I. Chromosomal Abnormalities, Cancer and Mouse Models: The Critical Role of Translocation-Associated Genes in Human Cancer. Current Genomics 2000; 1: 71–80
   Google Scholar
• McCulloch E. Stem cells in normal and leukemic hemopoiesis Henry Stratton Lecture. Blood 1983; 62: 1–13
   PubMed Web of Science ®Google Scholar
• Cashman J, Bockhold K, Hogge D E, Eaves A C, Eaves CJ. Sustained proliferation, multi-lineage differentiation and maintenance of primitive human hematopoietic cells in NOD/SCID mice transplanted with human cord blood. Br. J. Haematol 1997; 98: 1026–1036
   PubMed Web of Science ®Google Scholar
• Dick J E, Bathia M, Gan O, Kapp U, Wang JC. Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells 1997; 15: 199–203
   PubMed Web of Science ®Google Scholar
• Dao M A, Nolta JA. Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction. Int J Mol Med 1998; 1: 257–264
   PubMed Web of Science ®Google Scholar
• Bonnet D, Bhatia M, Wang J C, Kapp U, Dick JE. Cytokine treatment or accessory cells are required to initiate engrafment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant 1999; 23: 203–209
   PubMed Web of Science ®Google Scholar
• Greiner D L, Hesselton R A, Shultz LD. SCID mouse models of human stem cell engraftment. Stem Cells 1998; 16: 166–177
   PubMed Web of Science ®Google Scholar
• Bhatia M, Bonnet D, Murdoch B, Gan O I, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Medicine 1998; 4: 1038–1045
   PubMed Web of Science ®Google Scholar
• Cobaleda C., Gutiérrez-Cianca N., Pérez-Losada J., Flores T., García-Sanz R., González M., Sánchez-García I. A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia. Blood, 95: 1007–1013
   PubMed Web of Science ®Google Scholar
• Choo Y., Sánchez-García I., Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature 1994; 372: 642–645
   PubMed Web of Science ®Google Scholar
• García Hernández B, Sánchez-García I. Retroviral vector design for gene therapy of cancer: Specific inhibition and tagging of BCR-ABLp190 cells. Molecular Medicine 1996; 2: 125–133
   PubMed Web of Science ®Google Scholar
• García Hernández B., Castellanos A., López A., Orfao A., Sánchez-García I. Murine haematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 13239–13244
   PubMed Web of Science ®Google Scholar
• Cobaleda C., Sánchez-García I. In vivo inhibition by a site-specific catalytic RNA subunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. Blood 2000; 95: 731–737
   PubMed Web of Science ®Google Scholar
• Cobaleda C., Pérez-Losada J., Sánchez-García I. Chromosomal abnormalities and tumour development: from genes to therapeutical mechanisms. BioEssays 1998; 20: 922–930
   PubMed Web of Science ®Google Scholar
• Bonnet D., Dick J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoieitic cell. Nature Med. 1997; 3: 730–736
   PubMed Web of Science ®Google Scholar
• Fairbairn L. J., Cowling G. J., Reipert B. M., Dexter T. M. Suppression of apoptosis allows differentiation and development of a multipotent hematopoietic cell line in the absence of added growth factors. Cell 1993; 74: 823–833
   PubMed Web of Science ®Google Scholar
• Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C, Enver T. Multilineage gene expression precedes commitment in the hematopoietic system. Genes Dev 1997; 11: 774–785
   PubMed Web of Science ®Google Scholar
• Enver T, Greaves M. Loops, lineages, and leukemia. Cell 1998; 94: 9–12
   PubMed Web of Science ®Google Scholar
• Busslinger M, Nutt S L, Rolink AG. Lineage commitment in lymphopoiesis. Current Opinion in Immunology 2000; 12: 151–158
   PubMed Web of Science ®Google Scholar
• Henderson A., Calame K. Transcriptional regulation during B-cell development. Annu. Rev. Immunol. 1998; 16: 163–200
   PubMed Web of Science ®Google Scholar